AT1 Receptor Antagonism Is Proangiogenic in the Brain: BDNF a Novel Mediator
Ahmed Alhusban(University of Georgia), Susan C. Fagan(Georgia Regents Medical Center)
Cited by 67
Related Papers
Clinically Relevant Doses of Candesartan Inhibit Growth of Prostate Tumor Xenografts In Vivo through Modulation of Tumor Angiogenesis
|Journal of Pharmacology and Experimental Therapeutics|2014|37
Candesartan Induces a Prolonged Proangiogenic Effect and Augments Endothelium-Mediated Neuroprotection after Oxygen and Glucose Deprivation: Role of Vascular Endothelial Growth Factors A and B
|Journal of Pharmacology and Experimental Therapeutics|2014|32